Clinical Trial Update: PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Plerixafor in combination with vinorelbine for stem cell mobilization in patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Plerixafor (Plerixafor)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Myeloma | Phase 2 | Status: COMPLETED